Septerna
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Septerna and other ETFs, options, and stocks.About SEPN
Septerna, Inc. is a clinical-stage biotechnology company, which engages in pioneering a new era of G protein-coupled receptor oral small molecule drug discovery powered by proprietary Native Complex PlatformTM. Its pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases.
CEOJeffrey T. Finer
CEOJeffrey T. Finer
Employees75
Employees75
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2019
Founded2019
Employees75
Employees75
SEPN Key Statistics
Market cap1.18B
Market cap1.18B
Price-Earnings ratio-17.47
Price-Earnings ratio-17.47
Dividend yield—
Dividend yield—
Average volume312.98K
Average volume312.98K
High today$26.72
High today$26.72
Low today$24.44
Low today$24.44
Open price$24.84
Open price$24.84
Volume219.66K
Volume219.66K
52 Week high$30.50
52 Week high$30.50
52 Week low$4.17
52 Week low$4.17
Stock Snapshot
As of today, Septerna(SEPN) shares are valued at $26.38. The company's market cap stands at 1.18B, with a P/E ratio of -17.47.
On 2026-01-13, Septerna(SEPN) stock traded between a low of $24.44 and a high of $26.72. Shares are currently priced at $26.38, which is +7.9% above the low and -1.3% below the high.
Septerna(SEPN) shares are trading with a volume of 219.66K, against a daily average of 312.98K.
During the past year, Septerna(SEPN) stock moved between $4.17 at its lowest and $30.50 at its peak.
During the past year, Septerna(SEPN) stock moved between $4.17 at its lowest and $30.50 at its peak.
Analyst ratings
100%
of 8 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own SEPN. This list is generated using Robinhood data, and it’s not a recommendation.